LSBCF (LakeShore Biopharma Co) Accumulated Depreciation: $-44.09 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is LakeShore Biopharma Co Accumulated Depreciation?

LakeShore Biopharma Co LSBCF Accumulated Depreciation is $-44.09 Mil as of Mar. 2025.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

LakeShore Biopharma Co's quarterly accumulated depreciation declined from Mar. 2024 ($-43.83 Mil) to Sep. 2024 ($0.00 Mil) but then increased from Sep. 2024 ($0.00 Mil) to Mar. 2025 ($-44.09 Mil).

LakeShore Biopharma Co's annual accumulated depreciation increased from Mar. 2023 ($-30.29 Mil) to Mar. 2024 ($-43.83 Mil) and increased from Mar. 2024 ($-43.83 Mil) to Mar. 2025 ($-44.09 Mil).

LakeShore Biopharma Co Accumulated Depreciation Related Terms

LakeShore Biopharma Co Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Accumulated Depreciation Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Accumulated Depreciation
-24.90 -28.42 -30.29 -43.83 -44.09

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only -30.29 0.00 -43.83 0.00 -44.09

LakeShore Biopharma Co Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-44.09 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Accumulated Depreciation of $-44.09 Mil as of Mar. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Accumulated Depreciation too high?
LakeShore Biopharma Co's current Accumulated Depreciation is $-44.09 Mil.
How does LakeShore Biopharma Co's Accumulated Depreciation compare to ACUT and PPCB?
LakeShore Biopharma Co's Accumulated Depreciation of $-44.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Accumulated Depreciation is $-44.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Accumulated Depreciation of $-44.09 Mil. The current Accumulated Depreciation is $-44.09 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Accumulated Depreciation is $-44.09 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.